The aim of the study is to evaluate the anticancer effect of Limonia acidissima Linn. (Family Rutaceae) which has long been prescribed for various infectious and malignant diseases. The fruit extract of L. acidissima Linn. has been carried out by following due procedure. Cell lines, cultures were incorporated and procured for in-vitro and in-vivo study with reference to cell proliferation assay, cell viability assay and cell cycle analysis. The bio-assays of extracts from L. acidissima Linn. showed that a fraction (fraction 3) from an ethanolic extract had an anticancer effect on SKBR3 and MDA-MB-435 human breast cancer cells. The ED 50 value of L. acidissima Linn. fraction 3 was 56.07 and 30.61 μg/ml for SKBR3 and MDA-MB-435, respectively. After 48 h of exposure, this fraction at a concentration of 100 μg/ml, significantly reduced cell proliferation in both cancer cells. In MDA-MB-435 cells, cell cycle analysis showed that the fruit extract fraction 3 induced the accumulation of cells in G2/M phase, whereas no significant change in cell cycle was detected in SKBR3 cells. The results indicated that the extract fraction could induce cell cycle arrest in some way. However, further investigation is needed to assess the molecular mechanisms that mediated anticancer activities of this plant.
INTRODUCTION
Breast cancer is one of the most prevalent malignancies in women in many countries worldwide. In India, breast cancer is the second in frequency after cervical cancer, with an estimated incidence rate of 17.2 per 100,000 which has increased in all parts of the country during the past decade. Though the breast cancer therapy which is usually multimodality treatment is in advance, cytotoxic drugs still play the important roles for increasing survival rate together with good quality of life (Senthilkumar et al., 2010; Fargeot et al., 2004) . Therefore, the development and search for novel and effective anticancer agents have become very important issues (Cameron and Bell, 2004) . To date, many cytotoxic agents, including natural *Corresponding author. E-mail: deba_udps@yahoo.co.in. Tel: 9861137772. products isolated from plant sources have been investigated for the discovery of the potential novel anticancer drugs (Kirtikar and Basu, 2005) . Higher plants have long been shown to be excellent and reliable sources for the development of novel anticancer drugs. In India, many plants have been used for treatment of various malignancies over centuries. Limonia acidissima Linn, syn. Feronia limonia (Rutaceae) is a moderatesized deciduous tree grown throughout India. The fruits are woody, rough and used as a substitute for bael in diarrheoa and dysentery (Senthilkumar et al., 2010) . The bark and leaves of the plant are used for vitiated conditions of vata and pita while the fruits are used for tumours, asthma, wounds, cardiac debility and hepatitis. The fruit contains flavonoids, glycosides, saponins and tannins (Kirtikar and Basu, 2005) . Some coumarins (Kirtikar and Basu, 2005) and tyramine derivative (Llango and Chitra, 2010) have also been isolated from the fruits of Limonia. The leaves were reported to possess hepatoprotective activity (Rang et al., 1999) while the fruit shells contain antifungal compounds, namely, psoralene, xanthotoxin, 2, 6-dimethoxybenzoquinone and osthenol (Rubinstein et al., 1990) . However, the property of this plant, especially its anticancer activity, has not yet been investigated. Therefore, this prompted us to investigate the inhibitory growth effect of this plant on two different breast cancer cell lines, SKBR3 and MDA-MB-435.
MATERIALS AND METHODS

Plant material and extraction procedures
L. acidissima Linn. fruits were collected from forest division, Bhubaneswar hill area situated in the Eastern part of India, and was identified by Dr S. K. Sahu, a taxonomist at the Utkal University, Vanivihar, Orissa. A voucher specimen No. 161 was deposited at the same place. The fruits of this plant were cut into small pieces and ground into powder. The powder (1.5 kg) was macerated three times with 15 L of 95% ethanol for 7 days each (Llango and Chitra, 2010) . The extracts were concentrated under reduced pressure resulting in 80.50 g extract (DER = 25.5:1).
The ethanolic fruit extract (35 g) was dissolved in distilled water (100 ml) and column chromatographed was done for total volume of 15 ml which was dry packed using the glass column (4 cm inner diameter and 60 cm long) and equilibrated with water (100 ml) and sonicated for 15 min in an ultrasonic bath. The suspension was centrifuged at 20,000 rpm (about 42,000 ×g) for 30 min. The supernatant was applied onto the Diaion ® HP-20 column, and the eluent was collected to get the water soluble fraction (fraction 1) ( Figure 1 ). The precipitate was dissolved in ethanol-water (1:1/100 ml) and ethanol (150 ml) to get the fractions 2 and 3, respectively. Each supernatant was repeatedly performed as described earlier. The precipitate was dissolved in ethyl acetate to get fraction 4. The chemical composition of each fraction was monitored on thin layer chromatography (TLC). The fractions were on to silica gel GF254 Alufolien (Merck) and developed with a chloroform/ethanol (90:10, v/v). The phytosteryl glucoside was used as reference. After developing, the TLC was sprayed with anisaldehyde-sulfuric acid and heated in an oven at 100°C for 1 to 2 min. The ethanol fraction revealed eight bands. Three bands were yellow to orange with Rf values of 0.12, 0.25 and 0.30. Five bands were violet to blue with Rf values of 0.17, 0.38, 0.41, 0.56 and 0.61. The violet to blue reference compound appeared at the Rf value of 0.17.
Preparation of L. acidissima Linn. fruit extracts
All L. acidissima Linn. fruit extracts were dissolved in dimethyl sulfoxide (DMSO, Sigma, St. Louis, USA) except for the water fraction (fraction 1) which was dissolved in water. For all experiments, final concentrations of the tested compounds were prepared by diluting the stock with the culture medium.
Cell lines and culture
All the breast cancer cell lines, SKBR-3 (ATCC No. HTB-30) and MDA-MB-435 (ATCC No. HTB-129), were procured from New Scientific Agencies, Bangalore, India. SKBR-3 is human breast cancer cell line with over-expression of HER2/neu receptor and absence of ER receptor whereas MDA-MB-435 breast cancer cell line is absent ER receptor and also HER2/neu expression (Saima et al., 2000) . Cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM) (Promo Cell, Germany) supplemented with 10% heat-inactivated foetal bovine serum (Promo Cell, Germany) and 1% penicillin-streptomycin (Promo Cell, Germany). The cells were incubated at 37°C in a humidified atmosphere with 5% CO2.
Cell proliferation assay
Cell proliferation assay is done by taking a total of 1 × 10 4 cells per well was seeded in a 96-well plate. After 36 h of incubation, various concentrations of fruit extracts were added to the wells to get the final concentration of 1, 10, 100 and 500 μg/ml. Control groups were added with DMSO to get the final concentration of 1%. Doxorubicin was used as positive control. Then, cells were incubated for an additional 48 h. After 2 days, 50 μl of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) (Sigma) 1 mg/ml in phosphate buffer saline (PBS) was added to each well and incubated for 4 h at 37°C. The medium was removed and formazan was dissolved in DMSO and the optical density was measured at 590 mm using a Bio-assay reader (Biorad, USA) (Rubinstein et al., 1990) .
Cell viability assay
The cells were suspended in a 96-well plate at the same concentration as the cell proliferation assay and incubated for 24 h at 37°C with 5% CO2. Various concentrations of fruit extracts as indicated were added to each well including DMSO as control groups. After 48 h incubation, cells were trypsinized and viable cell counting was performed by enumerating cells which excluded trypan blue dye using a haemocytometer.
Cell cycle analysis
To determine the cell cycle, 1 × 10 6 cells were suspended in each tissue culture dish and treated with fruit extracts at a final concentration of 80 and 160 μg/ml for SKBR3. For MDA-MB-435, cells were treated with fruit extracts at a final concentration of 60 and 120 μg/ml. 1% DMSO was added to the control group. After treatment for 48 h, cells were collected and incubated with reagents as described in the protocol of the Cycle TEST™ PLUS DNA reagent kit (Becton Dickinson Immunocytometry System). The DNA content of cells was measured by flow cytometry (Saima et al., 2000) . All samples were analysed within 3 h by FACS carlibur using Cell Quest software.
Statistical analysis
The experiments were performed in triplicate. The data regarding cell proliferation and viability assay were expressed as means ± standard deviation. The values of ED50 were calculated by using R 2 equation. A P value less than 0.05 were considered significant.
RESULTS
The percentage of growth inhibition of the fruit extract on human breast cancer cells is as shown in Figure 2A and B. Fruit extracts from fractions 1 to 4 and also the crude extract (ethanolic extract) were used to determine the ED 50 value (50% inhibition of cancer cell growth) in two different breast cancer cell lines, SKBR3 and MDA-MB-435, with a final concentration ranging from 1 to 500 μg/ml. At 48 h, the ED 50 values of fraction 3 were 56.07 ± 3.77 and 30.61 ± 1.49 μg/ml for SKBR3 and MDA-MB-435, respectively. As fraction 3 was found to have an inhibitory growth effect on these cell lines, this fraction was used to investigate the further effects of this plant on these cells.
Effect of extract on cell viability
We also characterized the cytotoxic effect of L. acidissima Linn. on SKBR3 and MDA-MB-435 by conducting a cell viability assay stained with trypan blue. The culture of these two breast cancer cell lines was treated with fruit extract fraction 3 at final concentrations of 1, 10, 100 and 500 μg/ml for 48 h. The results indicated that at a concentration of 100 μg/ml. Both cell lines showed low viability of less than 50% as compared to that of the control group. No cell inhibition was observed at 10 μg/ml.
Cell cycle induced by extract
The effect of the fruit extract on cell cycle progression on SKBR3 and MDA-MB-435 was determined by flow cytometry. SKBR3 treated with fruit extract fraction 3 at final concentrations of 160 μg/ml, as shown in Figure 3A and B, showed slightly S phase block by decreasing the population of the S phase from 12.89 to 7.19%. For MDA-MB-435 cell cycle progression, the result showed that the Pradhan et al. , at different concentrations of 1, 10, 100 and 500 μg/ml for 48 h and the growth inhibition was determined using the MTT assay. The growth inhibition was calculated as the percentage of inhibition compared with that of the control. treated MDA-MB-435 cells at a concentration of 120 μg/ml increased the population of the G2/M phase from 24.41 to 45.65% when compared with that of the control groups ( Figure 4A and B) .
DISCUSSION
The plant ethanolic extract was fractionated in column chromatography, according to the compound polarity. The eluting solvents were transferred to the column, starting from water, water-ethanol (1:1), ethanol and ethyl acetate. They were subjected to the MTT test for antiproliferative activities. The water soluble fraction comprised the most polar compounds, that is, inorganic salts, sugars, amino acids and saponins, the water-ethanol soluble fraction contained the glycosides and the ethyl acetate is composed of the aglycones. The ethanolic extract showed the cytotoxicity against the SKBR3 and MDA-MB-435 breast cancer cell lines with the ED 50 values of 56.07 ± 3.77 and 30.61 ± 1.49 μg/ml, respectively. This inhibitory growth activity of the treated cells acted in a dose-dependent manner which was also confirmed by the cell viability with the trypan blue exclusion assay. Such observation, demonstrated that some active components of this plant should be in the ethanolic fraction. Figure 3A and B shows that SKBR3 cells treated with the fruit extract for 48 h slightly decreased in the number of cells in S phase, whereas MDA-MB-435 treated with the extract for 48 h remarkably accumulated in the G2/M phase of the cell cycle up to 45% as shown in Figure 4A and B. The results indicated that the fruit extract fraction 3 could suppress breast cancer cell lines proliferation especially MDA-MB-435 via the cell cycle blockage.
Many anticancer agents from plants that have been prescribed for treating malignancies nowadays inhibit cancer cell growth through cell cycle regulation, including the G2/M accumulation (Schiff et al., 1997) . It is well known that agents that affect the G2/M phase cell cycle arrest interact by targeting tubulin or disrupting the tubulin-microtubule equilibrium (Hadfield et al., 2003 and Hardman et al., 1996; Tanaka et al., 2004 
